Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily F Mason

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2020
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironmentSanjay S Patel, Mikel Lipschitz, Geraldine S Pinkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsetsRyan D Michalek, Valerie A Gerriets, Sarah R Jacobs, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
The Journal of Biological Chemistry|December 17, 2010
Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cellsJonathan L Coloff, Emily F Mason, Brian J Altman, et al.
International Journal of Laboratory Hematology|May 3, 2026
Practical Considerations in the Implementation of Peripheral Smear Review in the Clinical LaboratoryOlga Pozdnyakova, Lauren H Yaeger, Cara Lunn Shirai, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology GroupOlga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.
The Journal of Clinical Investigation|December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemiaTae Kon Kim, Xue Han, Qianni Hu, et al.
Leukemia & Lymphoma|March 24, 2023
Myeloid sarcoma with <i>NPM1</i> mutation may be clinically and genetically distinct from AML with <i>NPM1</i> mutation: a study from the Bone Marrow Pathology GroupMaximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2020
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironmentSanjay S Patel, Mikel Lipschitz, Geraldine S Pinkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsetsRyan D Michalek, Valerie A Gerriets, Sarah R Jacobs, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
The Journal of Biological Chemistry|December 17, 2010
Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cellsJonathan L Coloff, Emily F Mason, Brian J Altman, et al.
International Journal of Laboratory Hematology|May 3, 2026
Practical Considerations in the Implementation of Peripheral Smear Review in the Clinical LaboratoryOlga Pozdnyakova, Lauren H Yaeger, Cara Lunn Shirai, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology GroupOlga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.
The Journal of Clinical Investigation|December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemiaTae Kon Kim, Xue Han, Qianni Hu, et al.
Leukemia & Lymphoma|March 24, 2023
Myeloid sarcoma with <i>NPM1</i> mutation may be clinically and genetically distinct from AML with <i>NPM1</i> mutation: a study from the Bone Marrow Pathology GroupMaximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.
Pageof 4